Co‐formulated abacavir‐lamivudine‐zidovudine vs NNRTIs or PIs
CD4 cell count · patients with initial treatment of HIV infection in antiretroviral‐naive individuals
1 finding from 1 review
- Co‐formulated abacavir‐lamivudine‐zidovudine for initial treatment of HIV infection and AIDS 2013 · Cochrane Headline outcomes onlyno estimate extracted3 studies · 1687 participantsModerate